Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imatinib Therapy Response”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Not applicableNot Yet RecruitingNCT07724626
What this trial is testing

Hyperpolarized MRI for GIST on Imatinib

Who this might be right for
Imatinib Therapy ResponseGastrointestinal Stromal Tumor (GIST)
Chang Gung Memorial Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00787384
What this trial is testing

Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes

Who this might be right for
Hypereosinophilic SyndromeChronic Eosinophilic LeukemiaChronic Idiopathic Hypereosinophilia
Northern Italy Leukemia Group 25
Testing effectiveness (Phase 2)UnknownNCT06626984
What this trial is testing

Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis

Who this might be right for
SepsisFluid OverloadEndothelial Dysfunction+1 more
Belfast Health and Social Care Trust 65
Testing effectiveness (Phase 2)Study completedNCT00363649
What this trial is testing

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Testing effectiveness (Phase 2)UnknownNCT04578847
What this trial is testing

REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib)

Who this might be right for
Chronic Myeloid LeukemiaChronic Myeloid Leukemia in RemissionBCR-ABL Positive Chronic Myelogenous Leukemia
National Research Center for Hematology, Russia 100
Testing effectiveness (Phase 2)UnknownNCT01762969
What this trial is testing

Treatment Modification Based on Early Assessment of CML Patients

Who this might be right for
CML
Rabin Medical Center 300
Testing effectiveness (Phase 2)UnknownNCT01802450
What this trial is testing

Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
PETHEMA Foundation 18
Post-approval studies (Phase 4)Study completedNCT01243489
What this trial is testing

Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation

Who this might be right for
Chronic Myelogenous Leukemia (CML)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 104
Testing effectiveness (Phase 2)Study completedNCT00466726
What this trial is testing

Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 57
Large-scale testing (Phase 3)Study completedNCT01819389
What this trial is testing

Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance

Who this might be right for
Leukemia, Myeloid, Chronic, BCR-ABL Positive
Hospital Universitario Dr. Jose E. Gonzalez 10
Early research (Phase 1)Study completedNCT01933906
What this trial is testing

Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Arbeitsgemeinschaft medikamentoese Tumortherapie 12
Large-scale testing (Phase 3)UnknownNCT00297570
What this trial is testing

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Who this might be right for
Leukemia, Myeloid, Philadelphia-Positive
Sheba Medical Center 90
Testing effectiveness (Phase 2)Ended earlyNCT01866553
What this trial is testing

Nilotinib Plus Pegylated Interferon-α2b in CML

Who this might be right for
Chronic Myeloid Leukemia
Amsterdam UMC, location VUmc 20
Not applicableUnknownNCT00445822
What this trial is testing

Registration of Children With CML and Treatment With Imatinib

Who this might be right for
Myeloid Leukemia, Chronic
Technische Universität Dresden 150
Not applicableStudy completedNCT01188278
What this trial is testing

Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey

Who this might be right for
Leukemia, Myeloid, Chronic-Phase (CML-CP)
Bristol-Myers Squibb 173
Testing effectiveness (Phase 2)Study completedNCT01804985
What this trial is testing

De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia

Who this might be right for
Chronic Myeloid Leukaemia
University of Liverpool 174
Testing effectiveness (Phase 2)Study completedNCT01593254
What this trial is testing

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 262
Not applicableLooking for participantsNCT07091019
What this trial is testing

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

Who this might be right for
Chronic Myelogenous Leukemia - Chronic Phase
Novartis Pharmaceuticals 1,000
Testing effectiveness (Phase 2)UnknownNCT04043676
What this trial is testing

Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Fundación Teófilo Hernando, Spain 40
Large-scale testing (Phase 3)Ended earlyNCT02115386
What this trial is testing

Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib

Who this might be right for
Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
Novartis Pharmaceuticals 7
Next Page